We are live on ! Find out more
ANAB icon

AnaptysBio

122 hedge funds and large institutions have $720M invested in AnaptysBio in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 50 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more capital invested

Capital invested by funds: $628M → $720M (+$92M)

0% more funds holding

Funds holding: 122122 (0)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

5.08% less ownership

Funds ownership: 106.62%101.54% (-5.1%)

32% less call options, than puts

Call options by funds: $1.43M | Put options by funds: $2.11M

50% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 50

Holders
122
Holders Change
Holders Change %
0%
% of All Funds
2.12%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
16
Increased
25
Reduced
50
Closed
16
Calls
$1.43M
Puts
$2.11M
Net Calls
-$676K
Net Calls Change
-$406K
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$4.19M +$51.2K +2,136 +1%
Acadian Asset Management
27
Acadian Asset Management
Massachusetts
$4.18M +$408K +17,007 +12%
Charles Schwab
28
Charles Schwab
California
$3.7M +$170K +7,095 +5%
Los Angeles Capital Management
29
Los Angeles Capital Management
California
$3.27M +$1.2M +50,175 +66%
SG Americas Securities
30
SG Americas Securities
New York
$3.06M +$62K +2,586 +2%
Millennium Management
31
Millennium Management
New York
$2.79M +$2.58M +107,520 New
Massachusetts Financial Services
32
Massachusetts Financial Services
Massachusetts
$2.53M +$1.51M +63,124 +184%
Macquarie Group
33
Macquarie Group
Australia
$2.44M
Jacobs Levy Equity Management
34
Jacobs Levy Equity Management
New Jersey
$2.31M -$121K -5,039 -5%
HF
35
HRT Financial
New York
$2.25M +$2.08M +86,715 New
Connor, Clark & Lunn Investment Management (CC&L)
36
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.08M +$36.7K +1,532 +2%
Wells Fargo
37
Wells Fargo
California
$2.07M +$481K +20,077 +34%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$2.04M -$517K -21,578 -21%
Citigroup
39
Citigroup
New York
$1.99M -$901K -37,574 -33%
JAM
40
Jupiter Asset Management
United Kingdom
$1.53M +$1.41M +58,954 New
PPA
41
Parametric Portfolio Associates
Washington
$1.32M -$76.8K -3,203 -6%
Rafferty Asset Management
42
Rafferty Asset Management
New York
$1.24M -$1.03M -42,840 -47%
Voloridge Investment Management
43
Voloridge Investment Management
Florida
$1.17M -$95.8K -3,996 -8%
Axa
44
Axa
France
$1.03M +$949K +39,600 New
Swiss National Bank
45
Swiss National Bank
Switzerland
$1.02M -$393K -16,400 -29%
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$979K +$883K +36,843 +3,945%
AA
47
ALPS Advisors
Colorado
$935K -$322K -13,429 -27%
ECM
48
ExodusPoint Capital Management
New York
$873K +$807K +33,679 New
AllianceBernstein
49
AllianceBernstein
Tennessee
$788K +$69.5K +2,900 +11%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$783K -$162K -6,752 -18%

ANAB Hedge Fund Activity: Q2 2021 in Review

122 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q2 2021, worth a combined $720M — up 15% from $628M a quarter earlier.

Fund positioning in ANAB was balanced in Q2 2021: 16 funds opened new positions, 16 closed out, 25 added to existing stakes and 50 trimmed.

The largest buyer was Great Point Partners, opening a new position worth an estimated $9.59M. The largest seller was State Street, cutting an estimated $11.5M.

  • 122 institutional investors held AnaptysBio (ANAB) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $720M of AnaptysBio stock for Q2 2021, up 15% quarter-over-quarter.
  • 16 funds opened new AnaptysBio positions in Q2 2021 and 16 closed out, a net change of 0 holders.
  • The largest AnaptysBio buyer in Q2 2021 was Great Point Partners, an estimated $9.59M added.
  • The largest AnaptysBio seller in Q2 2021 was State Street, an estimated $11.5M sold.

Based on aggregated 13F filings for Q2 2021.